- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 295/03 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
Patent holdings for IPC class C07D 295/03
Total number of patents in this class: 142
10-year publication summary
|
8
|
11
|
8
|
6
|
14
|
14
|
5
|
5
|
6
|
7
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| BASF SE | 20874 |
7 |
| University of Maryland, Baltimore | 1013 |
5 |
| Tower Engineering Solutions, LLC | 15 |
5 |
| Evonik Degussa GmbH | 1537 |
4 |
| National University Corporation Hokkaido University | 1340 |
4 |
| Noramco, LLC | 27 |
4 |
| The Regents of the University of California | 19859 |
3 |
| The Board of Trustees of the University of Illinois | 2685 |
3 |
| Osaka University | 3374 |
3 |
| Novo Nordisk A/S | 2290 |
3 |
| Purdue Research Foundation | 3576 |
2 |
| Eli Lilly and Company | 3829 |
2 |
| Infineum International Limited | 388 |
2 |
| N.E. Chemcat Corporation | 188 |
2 |
| POLA Chemical Industries Inc. | 90 |
2 |
| Shionogi & Co., Ltd. | 860 |
2 |
| Reneo Pharmaceuticals, Inc. | 21 |
2 |
| Esteve Pharmaceuticals, S.A. | 216 |
2 |
| Aligos Therapeutics, Inc. | 150 |
2 |
| Honour (R&D) | 6 |
2 |
| Other owners | 81 |